These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 24954507)

  • 1. PHLDA1 expression is controlled by an estrogen receptor-NFκB-miR-181 regulatory loop and is essential for formation of ER+ mammospheres.
    Kastrati I; Canestrari E; Frasor J
    Oncogene; 2015 Apr; 34(18):2309-16. PubMed ID: 24954507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional up-regulation of PHLDA1 by 17beta-estradiol in MCF-7 breast cancer cells.
    Marchiori AC; Casolari DA; Nagai MA
    Braz J Med Biol Res; 2008 Jul; 41(7):579-82. PubMed ID: 18641796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways.
    Keklikoglou I; Koerner C; Schmidt C; Zhang JD; Heckmann D; Shavinskaya A; Allgayer H; Gückel B; Fehm T; Schneeweiss A; Sahin O; Wiemann S; Tschulena U
    Oncogene; 2012 Sep; 31(37):4150-63. PubMed ID: 22158050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-191/DAB2 axis regulates the tumorigenicity of estrogen receptor-positive breast cancer.
    Tian X; Zhang Z
    IUBMB Life; 2018 Jan; 70(1):71-80. PubMed ID: 29247596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-301a-3p Suppresses Estrogen Signaling by Directly Inhibiting ESR1 in ERα Positive Breast Cancer.
    Lettlova S; Brynychova V; Blecha J; Vrana D; Vondrusova M; Soucek P; Truksa J
    Cell Physiol Biochem; 2018; 46(6):2601-2615. PubMed ID: 29763890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proinflammatory cytokines enhance estrogen-dependent expression of the multidrug transporter gene ABCG2 through estrogen receptor and NF{kappa}B cooperativity at adjacent response elements.
    Pradhan M; Bembinster LA; Baumgarten SC; Frasor J
    J Biol Chem; 2010 Oct; 285(41):31100-6. PubMed ID: 20705611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive cross-talk between estrogen receptor and NF-kappaB in breast cancer.
    Frasor J; Weaver A; Pradhan M; Dai Y; Miller LD; Lin CY; Stanculescu A
    Cancer Res; 2009 Dec; 69(23):8918-25. PubMed ID: 19920189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of glioma-associated oncogene homolog 1 (GLI1) expression in claudin-low breast cancer and crosstalk with the nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB) pathway.
    Colavito SA; Zou MR; Yan Q; Nguyen DX; Stern DF
    Breast Cancer Res; 2014 Sep; 16(5):444. PubMed ID: 25252859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway.
    Wu H; Li J; Guo E; Luo S; Wang G
    Cell Physiol Biochem; 2018; 48(2):461-474. PubMed ID: 30016800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-194 ameliorates hepatic ischemia/reperfusion injury via targeting PHLDA1 in a TRAF6-dependent manner.
    Luo YH; Huang ZT; Zong KZ; Cao ZR; Peng DD; Zhou BY; Shen A; Yan P; Wu ZJ
    Int Immunopharmacol; 2021 Jul; 96():107604. PubMed ID: 33839577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on the Role of NFκB in Promoting Aggressive Phenotypes of Estrogen Receptor-Positive Breast Cancer.
    Smart E; Semina SE; Frasor J
    Endocrinology; 2020 Oct; 161(10):. PubMed ID: 32887995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PHLDA1 (pleckstrin homology-like domain, family A, member 1) knockdown promotes migration and invasion of MCF10A breast epithelial cells.
    Bonatto N; Carlini MJ; de Bessa Garcia SA; Nagai MA
    Cell Adh Migr; 2018 Jan; 12(1):37-46. PubMed ID: 28640659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PHLDA1 is a crucial negative regulator and effector of Aurora A kinase in breast cancer.
    Johnson EO; Chang KH; de Pablo Y; Ghosh S; Mehta R; Badve S; Shah K
    J Cell Sci; 2011 Aug; 124(Pt 16):2711-22. PubMed ID: 21807936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A miR-26a/E2F7 feedback loop contributes to tamoxifen resistance in ER-positive breast cancer.
    Liu J; Li X; Wang M; Xiao G; Yang G; Wang H; Li Y; Sun X; Qin S; Du N; Ren H; Pang Y
    Int J Oncol; 2018 Oct; 53(4):1601-1612. PubMed ID: 30066905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NFκB affects estrogen receptor expression and activity in breast cancer through multiple mechanisms.
    Frasor J; El-Shennawy L; Stender JD; Kastrati I
    Mol Cell Endocrinol; 2015 Dec; 418 Pt 3(0 3):235-9. PubMed ID: 25450861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-221/222 promote cancer stem-like cell properties and tumor growth of breast cancer via targeting PTEN and sustained Akt/NF-κB/COX-2 activation.
    Li B; Lu Y; Yu L; Han X; Wang H; Mao J; Shen J; Wang B; Tang J; Li C; Song B
    Chem Biol Interact; 2017 Nov; 277():33-42. PubMed ID: 28844858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A MicroRNA196a2* and TP63 circuit regulated by estrogen receptor-α and ERK2 that controls breast cancer proliferation and invasiveness properties.
    Kim K; Madak-Erdogan Z; Ventrella R; Katzenellenbogen BS
    Horm Cancer; 2013 Apr; 4(2):78-91. PubMed ID: 23250869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNFalpha up-regulates SLUG via the NF-kappaB/HIF1alpha axis, which imparts breast cancer cells with a stem cell-like phenotype.
    Storci G; Sansone P; Mari S; D'Uva G; Tavolari S; Guarnieri T; Taffurelli M; Ceccarelli C; Santini D; Chieco P; Marcu KB; Bonafè M
    J Cell Physiol; 2010 Nov; 225(3):682-91. PubMed ID: 20509143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen promotes stemness and invasiveness of ER-positive breast cancer cells through Gli1 activation.
    Sun Y; Wang Y; Fan C; Gao P; Wang X; Wei G; Wei J
    Mol Cancer; 2014 Jun; 13():137. PubMed ID: 24889938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-191, an estrogen-responsive microRNA, functions as an oncogenic regulator in human breast cancer.
    Nagpal N; Ahmad HM; Molparia B; Kulshreshtha R
    Carcinogenesis; 2013 Aug; 34(8):1889-99. PubMed ID: 23542418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.